Bevacizumab induced hypertension in gynecologic cancer: Does it resolve after completion of therapy?

• Главные авторы: Bradley R. Corr (Автор), Christopher Breed (Автор), Jeanelle Sheeder (Автор), Sarah Weisdack (Автор), Kian Behbakht (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2016-08-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Hypertension (HTN) induced by bevacizumab is a side effect that is often thought to resolve after treatment. However, there are currently no reports on rates of resolution. We assess the incidence and timing of the resolution of bevacizumab induced HTN. We evaluated all patients treated with bevaciz...